RSV Prevention: 5 Things Parents Must Know about Beyfortus (Nirsevimab)

• 2025

  Log in to bookmark this resource.

  Log in
• Susannah Franco

---

Access Resources

• LectureEN
• Ask aRCie About This Resource

About

This video describes five key points about Beyfortus (nirsevimab), a new drug for RSV prevention in infants. Nirsevimab is a monoclonal antibody that provides immediate protection against severe RSV, unlike traditional vaccines. It is important because RSV can cause serious lung infections in young children. The drug is recommended for babies entering their first or second RSV season, especially those at higher risk. It is given as a single injection and lasts at least 5 months. Nirsevimab has been tested and found safe with mild side effects like redness or low-grade fever being common.

---

Tags

Focus Area: Infectious Disease

Audience: Families & Children

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Bronchiolitis; Chronic Disease; Heart Defects, Congenital; Immunization, Passive; Infant, Newborn; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Premature Birth

Institutions: Pharmacy Consult with Dr. Su

---

More like this

Nirsevimab (Beyfortus): RSV Protection for Infants 2025 · Pharmacy Consult with Dr. Su Understanding Parvovirus B19, Symptoms, Prevention, and Concerns 2024 · Bee Kind Pediatrics Sepsis and Kids: A Public Information Forum with Experts from Perth Children's Hospital 2024 · Perth Children's Hospital

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---